Pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients after acute dosage

1978 ◽  
Vol 14 (4) ◽  
pp. 267-271 ◽  
Author(s):  
D. P. Thornhill
1979 ◽  
Vol 2 (7) ◽  
pp. 382-382 ◽  
Author(s):  
Gordon Johnson ◽  
Glenn Hunt ◽  
David Jackson ◽  
Tim Richards ◽  
Eddie Kwan

1970 ◽  
Vol 5 (2-4) ◽  
pp. 183-186 ◽  
Author(s):  
A. Coppen ◽  
J. Bailey

1991 ◽  
Vol 37 (7) ◽  
pp. 1205-1209 ◽  
Author(s):  
Richard C Friedberg ◽  
Daniel A Spyker ◽  
David A Herold

Abstract Clinically significant delayed absorption after lithium overdose has been reported previously without adequate explanation. We have studied two patients after they took massive intentional lithium overdoses. The first patient presented shortly after ingesting 74 g of lithium carbonate. Pharmacokinetic analysis with a multicompartmental model of 29 serum lithium concentrations during 300 h (including hemodialysis) established absorption and elimination kinetics. Lithium absorption was both slow (peak concentration 33 h after the initial overdose) and delayed (a second peak occurred at 148 h, 30 h after initiation of oral tube feedings). The delayed absorption of a large fraction of lithium implicated a gastrointestinal drug reservoir. Study of the pharmacokinetics in a second patient, who ingested 98 g of lithium carbonate, provided additional evidence of an endogenous reservoir. This patient's medical management was guided by experience gained from the initial case. Appropriate management for a predicted endogenous drug reservoir may have shortened intensive care and hospitalization. In treating overdoses of sustained-release drug preparations, clinically significant delayed absorption triggered by enteral fluids must be considered as a contributor to delayed absorption.


1978 ◽  
Vol 19 (2) ◽  
pp. 119-120 ◽  
Author(s):  
N.Rama Krishna ◽  
Michael A. Taylor ◽  
Richard Abrams

1988 ◽  
Vol 153 (2) ◽  
pp. 198-204 ◽  
Author(s):  
R. M. Lusznat ◽  
D. P. Murphy ◽  
C. M. H. Nunn

Fifty-four acutely manic patients were allocated to treatment on a double-blind basis with either carbamazepine or lithium carbonate. The short-term effects of treatment were studied over a period of six weeks and the longer term, prophylactic, effects over a period of up to a year. Additional ‘rescue’ medication was allowed when clinically indicated. There was a high drop-out rate from the trial. Despite this, it appeared that valid comparisons between the two treatments could be made. No statistically significant differences were found, but carbamazepine appeared slightly less effective as a treatment for acute mania and more effective as a prophylactic treatment in this group of patients. Possible predictors of individual responsiveness to each treatment are discussed.


Sign in / Sign up

Export Citation Format

Share Document